Compare XBIO & YMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XBIO | YMAT |
|---|---|---|
| Founded | N/A | 1970 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7M | 4.5M |
| IPO Year | 2011 | 2021 |
| Metric | XBIO | YMAT |
|---|---|---|
| Price | $1.66 | $1.20 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 22.3K | ★ 4.0M |
| Earning Date | 11-24-2026 | 10-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.52 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,976,411.00 | N/A |
| Revenue This Year | $2.37 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $10.92 |
| Revenue Growth | ★ 19.04 | N/A |
| 52 Week Low | $1.58 | $0.24 |
| 52 Week High | $4.94 | $4.49 |
| Indicator | XBIO | YMAT |
|---|---|---|
| Relative Strength Index (RSI) | 35.30 | 43.11 |
| Support Level | $1.58 | $0.32 |
| Resistance Level | $3.21 | $2.20 |
| Average True Range (ATR) | 0.20 | 0.30 |
| MACD | 0.01 | -0.07 |
| Stochastic Oscillator | 22.89 | 23.05 |
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immuno-oncology technologies addressing difficult-to-treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors. Its product pipeline consists of two key programs, XBIO-015 and XBIO-020, which are being developed to address pancreatic carcinoma and solid tumours.
J-Star Holding Co Ltd is engaged in the research, development, and manufacturing of carbon fiber for a wide variety-of-products including carbon bicycles, carbon rackets, automotive parts, outdoor sports gears, and healthcare products. The company has five segments: Bicycle frame, Racket, Crank, Service provision, and Others. The majority of its revenue is generated from the Bicycle frame segment. Geographically, the company operates in Taiwan, China, and other regions.